Literature DB >> 1606720

Clusterin in renal tissue: preferential localization with the terminal complement complex and immunoglobulin deposits in glomeruli.

L E French1, J Tschopp, J A Schifferli.   

Abstract

The membrane attack complex (MAC) of complement is activated by immune and non-immune mechanisms in the kidney. MAC has been found associated with glomerular immune deposits, but also to cell remnants, particularly along tubules and in vessel walls. Clusterin and S-protein (vitronectin) bind to MAC, rendering it cytolytically inactive. Both have been found associated with MAC in renal tissue. Here we analysed the deposition of clusterin and S-protein in 118 renal biopsies relative to the localization of the MAC using MoAbs. Statistical analysis was performed comparing no or little versus evident or strong staining by immunofluorescence (IF). In glomeruli, out of the 92 biopsies where both MAC and immunoglobulins were evaluated, deposits of MAC were found in the presence (32 out of 41) but also in the absence of immunoglobulins (20/51). Clusterin and S-protein deposits were seen, respectively, in 25 out of 61 and 36 out of 61 biopsies containing glomerular MAC, and almost never in its absence (one out of 50 for both). The association of the two inhibitors with MAC was observed mainly in glomeruli containing immunoglobulin deposits (respectively, 21 out of 32 and 25 out of 32), but not when immunoglobulins were absent (three out of 20 and seven out of 20) (coefficient of concordance, K = 0.47 and 0.43). The localization of MAC along tubules and in vessels was easily identified in most biopsies (93 out of 118) and was accompanied by S-protein in most cases (tubules, 86 out of 93; vessels, 82 out of 93) (K = 0.58 and 0.57 respectively) but not by clusterin (28 out of 93 and 24 out of 93). These results suggest that clusterin does not co-localize with MAC whenever there is formation and fixation of the MAC. It seems that clusterin has a particular affinity for MAC which is associated with immunoglobulin. This observation should help to distinguish between the different forms of MAC, and might indicate that MAC associated with immunoglobulin is essentially in its cytolytically inactive form.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1606720      PMCID: PMC1554498          DOI: 10.1111/j.1365-2249.1992.tb06459.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.

Authors:  L S Zalman; L M Wood; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

2.  Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.

Authors:  S Bhakdi; R Käflein; T S Halstensen; F Hugo; K T Preissner; T E Mollnes
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

3.  Immunohistochemical demonstration of age-related deposition of vitronectin (S-protein of complement) and terminal complement complex on dermal elastic fibers.

Authors:  K Dahlbäck; H Löfberg; J Alumets; B Dahlbäck
Journal:  J Invest Dermatol       Date:  1989-05       Impact factor: 8.551

4.  Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.

Authors:  J Bariety; N Hinglais; S Bhakdi; C Mandet; M Rouchon; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

5.  Localization of clusterin in the epimembranous deposits of passive Heymann nephritis.

Authors:  A A Eddy; I B Fritz
Journal:  Kidney Int       Date:  1991-02       Impact factor: 10.612

6.  Release of C8 binding protein (C8bp) from the cell membrane by phosphatidylinositol-specific phospholipase C.

Authors:  G M Hänsch; P F Weller; A Nicholson-Weller
Journal:  Blood       Date:  1988-09       Impact factor: 22.113

7.  Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma.

Authors:  D E Jenne; B Lowin; M C Peitsch; A Böttcher; G Schmitz; J Tschopp
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

8.  Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue.

Authors:  R J Falk; E Podack; A P Dalmasso; J C Jennette
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

9.  Localization of terminal complement components S-protein and SP-40,40 in renal biopsies.

Authors:  B F Murphy; D J Davies; W Morrow; A J d'Apice
Journal:  Pathology       Date:  1989-10       Impact factor: 5.306

10.  Molecular cloning of S-protein, a link between complement, coagulation and cell-substrate adhesion.

Authors:  D Jenne; K K Stanley
Journal:  EMBO J       Date:  1985-12-01       Impact factor: 11.598

View more
  18 in total

1.  V-src-induced-transcription of the avian clusterin gene.

Authors:  Y Herault; G Chatelain; G Brun; D Michel
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

2.  Identification of human plasma proteins as major clients for the extracellular chaperone clusterin.

Authors:  Amy R Wyatt; Mark R Wilson
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

3.  Potential role of apolipoprotein-E in fibrillogenesis.

Authors:  G Gallo; T Wisniewski; N H Choi-Miura; J Ghiso; B Frangione
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

Review 4.  Primary Membranous Nephropathy.

Authors:  William G Couser
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-26       Impact factor: 8.237

5.  Tubular up-regulation of clusterin mRNA in murine lupus-like nephritis.

Authors:  S Moll; P A Menoud; L French; A P Sappino; Y Pastore; J A Schifferli; S Izui
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

6.  Clusterin promotes the aggregation and adhesion of renal porcine epithelial cells.

Authors:  J R Silkensen; K M Skubitz; A P Skubitz; D H Chmielewski; J C Manivel; J A Dvergsten; M E Rosenberg
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

7.  Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC).

Authors:  A K Chauhan; T L Moore
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

8.  The kinetics and distribution of C9 and SC5b-9 in vivo: effects of complement activation.

Authors:  J D Greenstein; P W Peake; J A Charlesworth
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

9.  Structural characterization of clusterin-chaperone client protein complexes.

Authors:  Amy R Wyatt; Justin J Yerbury; Mark R Wilson
Journal:  J Biol Chem       Date:  2009-06-17       Impact factor: 5.157

10.  Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus.

Authors:  L E French; A P Sappino; J Tschopp; J A Schifferli
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.